Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

A patient with complete hair loss regrew all her hair using tofacitinib.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Bimekizumab effectively treated a man's chronic beard hair loss.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Bioregulatory medicine improved the dog's health and recovery from chemotherapy side effects.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

GI197111X is best dissolved in Capmul MCM for trials.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

The combination of tretinoin, minoxidil, and betamethasone valerate may cause severe scalp inflammation.

Sonidegib often causes hair loss, and LC-OCT helps identify early signs.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

Ruxolitinib can help regrow hair in severe alopecia areata.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Biotrinine® may be an effective treatment for chronic hair loss.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Sorafenib can cause a temporary skin condition that goes away after stopping the drug.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

Baricitinib can cause excessive hair growth.

Targeting lipid metabolism can help treat advanced, resistant cancers.